Insight Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,592	Closed	-$213K	–	290
2025 Q2	$213K	Sell	4,592 -61	-1%	-$2.99K	0.03%	267
2025 Q1	$284K	Buy	4,653 +382	+9%	+$22.3K	0.05%	225
2024 Q4	$239K	Buy	4,271 +80	+2%	+$4.47K	0.04%	259
2024 Q3	$217K	Buy	+4,191	New	+$197K	0.04%	279
2024 Q2	–	Sell	-4,271	Closed	-$232K	–	293
2024 Q1	$232K	Sell	4,271 -48	-1%	-$2.44K	0.05%	270
2023 Q4	$222K	Sell	4,319 -257	-6%	-$13.5K	0.05%	259
2023 Q3	$266K	Sell	4,576 -1,731	-27%	-$106K	0.06%	222
2023 Q2	$403K	Buy	6,307 +38	+0.6%	+$2.55K	0.09%	170
2023 Q1	$435K	Sell	6,269 -194	-3%	-$13.7K	0.1%	171
2022 Q4	$467K	Buy	6,463 +118	+2%	+$8.9K	0.16%	166
2022 Q3	$451K	Buy	6,345 +65	+1%	+$4.71K	0.18%	151
2022 Q2	$453K	Sell	6,280 -241	-4%	-$18.4K	0.15%	168
2022 Q1	$476K	Sell	6,521 -98	-1%	-$6.58K	0.14%	182
2021 Q4	$413K	Sell	6,619 -720	-10%	-$42.2K	0.12%	202
2021 Q3	$435K	Buy	7,339 +51	+0.7%	+$3.36K	0.13%	194
2021 Q2	$496K	Sell	7,288 -923	-11%	-$60.2K	0.16%	170
2021 Q1	$513K	Buy	8,211 +416	+5%	+$25.9K	0.16%	157
2020 Q4	$484K	Buy	+7,795	New	+$479K	0.18%	145